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CASE REPORT
A 36-year-old young female came to the out-patient department with 
complaint of a progressively increasing lump in right breast for 1.5 
years. There was also an associated history of a palpable swelling 
in right axilla; and sudden increase in breast lump with development 
of redness of overlying skin, multiple skin nodules over the lump 
and peri-areolar skin denudation for last two months. Patient had 
painless progressive bilateral (left earlier than right) diminution of 
vision for last five years with inability to see from both eyes for last 
five months. Patient also complained of anorexia and weight loss 
for last two months. 
There was no history of bone or joint pain, pain abdomen, jaundice, 
vomiting, melena, breathlessness, cough, haemoptysis, headache, 
seizures or any other swelling in the body. There was also no history 
of trauma to eyes, watering, glares, floaters or redness of eyes. For 
these complaints patient had consulted local practitioners in nearby 
town multiple times but due to her poor financial status could not 
afford the treatment costs associated with surgery. There was no 
history suggestive of diabetes mellitus, hypertension, tuberculosis 
or history of any other malignancy in any of the first or second 
degree relatives of the patient. Patient had neither any addiction to 
alcohol or tobacco nor history of any drug intake. Patient was P1+0L1 
with first and only pregnancy at the age of 28 years. Patient had no 
menstrual complaints.
On examination, patient had a 10×8 cm diffuse mass with ill-defined 
margins involving whole of the right breast. The overlying skin had 
erythema, multiple small skin nodules, peau d’orange appearance 
and nipple retraction [Table/Fig-1]. The mass was fixed to the skin, 
breast tissue and chest wall. Multiple anterior and central group 
(level I) lymph nodes were enlarged in right axilla. The other breast 
and axilla were clinically disease-free. Patient had bilateral mature 
nuclear sclerosis type of cataract with only light perception in both 
eyes [Table/Fig-2]. Other bodily systems were clinically normal. 
Patient’s Body Mass Index (BMI) was 23.5. Routine laboratory 
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AbSTRACT 
A recent nation-wide population based retrospective cohort study from Taiwan in 2014 suggested a propensity of developing breast 
cancer in young females with early-onset cataract. We report here a case of a young non-obese female who presented to us with 
a large lump in the right breast with skin nodules and bilateral painless progressive diminution of vision. Patient was diagnosed to 
be suffering from locally advanced carcinoma of right breast with axillary metastasis (Stage III B) and bilateral early-onset nuclear 
cataract. Patient was started on taxane and anthracycline based neoadjuvant chemotherapy and after three cycles of chemotherapy 
patient showed partial response (≈50% reduction of tumour mass). Patient underwent small incision cataract surgery in left eye 
after the first cycle of chemotherapy. However, the patient was lost before any operative intervention could be done as she died 
in a road traffic accident. Possible mechanism of development of breast cancer in patients with early-onset cataract is discussed. 
This is the first reported case of a patient of early–onset cataract developing breast cancer as well as the first reported case of 
concomitant presence of early-onset bilateral cataract with breast cancer.
[Table/Fig-1]: (a) Right breast mass with overlying skin denudation and peau 
d’orange at presentation; (b) Same breast mass after three cycles of neoadjuvant 
chemotherapy showing ≈50% reduction in size, disappearance of skin denudation 
and right axillary lymph nodes.
parameters like haemogram, blood sugar, renal functions, liver 
functions were within normal limits. HbA1c of the patient was 5.3. 
Mammography revealed thickening of overlying skin with presence 
of a large dense soft-tissue mass with speculated margins involving 
right breast with focal areas of pleomorphic microcalcifications.
A Contrast-Enhanced Magnetic Resonance Imaging (CE-MRI) with 
dedicated breast coils of bilateral breast revealed presence of a 
large ill-defined altered signal intensity infiltrative mass lesion (7.2 
× 6.7 × 7.6 cm) involving almost the entire right breast showing 
heterogeneous enhancement in post-contrast sequences with 
multiple areas of nodular enhancement with diffuse thickening of 
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the skin with chest wall invasion with few enlarged nodes in right 
axilla [Table/Fig-3]. Left breast and axilla were essentially normal. A 
core needle biopsy was done which showed presence of infiltrating 
ductal carcinoma of breast with triple-negative hormone receptor 
status. The chest x-ray; skull x-ray; NCCT of head; x-ray of cervical, 
dorsal, lumbar and sacral spine; x-ray pelvis and long bones; MRI 
spine screening, ultrasonography of abdomen, contrast enhanced 
computed tomography of chest and abdomen of the patient were 
found to be within normal limits.
A bone scan or positron emission tomography of the patient 
could not be done due to non-availability of same at our center. 
Genetic testing could not be carried out in the patient due to 
financial constraints. Patient was diagnosed with locally advanced 
carcinoma of right breast T4bN2aM0 (stage IIIB) with bilateral early-
onset nuclear sclerosis-type mature cataract.
Patient was started on epirubicin, cyclophosphamide and docetaxel 
neoadjuvant chemotherapy. She developed hyperglycaemia 
after second cycle of chemotherapy with fasting glucose levels 
of 135 mg%, postprandial levels of 190 mg% and HbA1C of 6.3 
at ninth week. She was started on metformin which controlled 
hyperglycaemia adequately. She tolerated first three cycles of 
chemotherapy well with a partial clinical response in the form of 
≈50% reduction in tumour size [Table/Fig-1] but complete clinical 
disappearance of axillary nodes (early-responder). Small-incision 
cataract surgery was performed in left eye after first cycle of 
neoadjuvant chemotherapy [Table/Fig-2] and in right eye; it was 
planned before the fourth cycle of chemotherapy. There was good 
restoration of vision (6/9) in her right eye when she reported at 
the time of third cycle of chemotherapy. Patient was planned for 
a modified radical mastectomy with adjuvant chemoradiation after 
achieving a complete clinico-radiological response to chemotherapy; 
however she died in a road traffic accident when she was returning 
home after the third cycle of chemotherapy. 
DISCUSSION
Cataract may be present in patients presenting with carcinoma breast 
especially in elderly females. This is especially true for elderly post-
menopausal females. Age-related cataract usually occur in patients 
older than 50 years [1], but some patients experience cataracts 
before this age which is referred to as Early Onset Cataract (EOC). 
In a nation-wide population based retrospective cohort study by 
Chiang CC et al., in Taiwan, an increased incidence of breast, liver, 
and head and neck cancers was observed in patients presenting 
with EOC [2].
Our patient was a young non-obese female who started developing 
vision loss at age of around 31 years and by the time she presented 
to us with right sided breast lump at the age of around 36 years; 
she had nuclear sclerosis type bilateral mature early onset-cataract 
with complete loss of vision except light perception. In the absence 
of any form of trauma and other co-morbidities, our patient can be 
labelled as to be suffering from EOC. This is the first reported case 
of concomitant presence of EOC with breast cancer as well as first 
reported case of a patient of EOC developing breast cancer and 
may indicate a potential association.
EOC is thought to be due to insufficient anti-oxidative function [1,2]. 
Carcinogenesis is similarly related to oxidative stress and oxidative 
damage [3]. The possible mechanisms for this association can be 
linked to metabolic syndrome [4-6], Reactive Oxygen Species (ROS) 
[7,8], genetic factors [9,10] and environmental factors [11-13].
Forte et al., found that diabetes and obesity are linked closely 
and both in turn are associated with an increased incidence of 
solid tissue cancers [4]. Tan JS et al., reported in their study that 
metabolic syndrome is associated with all three types of cataracts 
(nuclear, cortical, and posterior sub-capsular cataracts) [5]. Thus, 
we saw that metabolic syndrome is a precursor of both cancer 
as well as cataract. However, our patient was neither obese nor 
predisposed to any metabolic abnormality so metabolic syndrome 
was an unlikely cause linking EOC with breast cancer in our case. 
Hyperglycaemia that developed in our patient after the second 
cycle of chemotherapy may be attributed to chemotherapy as 
cyclophosphamide and epirubicin have been implicated as causes 
of hyperglycaemia and diabetes mellitus [6].
ROS alter gene expression patterns and thus contribute to 
carcinogenesis through oxidative stress in fibroblasts which 
then proliferate uncontrollably [3]. ROS lead to lens opacification 
through oxidative damage to lens proteins [7]. Moreover oxidative 
damage associated with Ultraviolet (UV) light plays a key role in 
the development of cataracts [8]. So, if the anti-oxidative function 
is maleficent at a younger age, EOC may occur because ROS-
damaged DNA cannot be repaired, leading to a higher cancer 
possibility in young adults. This might have been a contributory 
factor in our patient; however further testing was required to prove 
any association which was not done in our case.
Saadat I et al., found an increased incidence of cataract in subjects 
with the null genotype of Glutathione S-Transferase M1 subtype 
(GSTM1) (odds ratio-1.51; p<0.05) [9]. The polymorphisms of 
GSTM1, GSTT1, GSTP1 and GSTO2 have been shown to be 
associated with increased risk of developing breast cancer [10]. 
Thus, the polymorphism of GST may be a possible link between EOC 
and carcinogenesis. Genetic factors could have been a potential 
culprit in our patient in development of EOC and subsequent BC, 
but we could not investigate for GST polymorphism in our patient.
Wide use of chemicals in our daily lives could also be a potential 
link relating EOC and cancer. Glyphosate is one such herbicide 
which is now a major crop management strategy for pre-harvest 
desiccation of perennial weed control especially with Genetically 
Modified (GM) crops [11]. Multiple genotoxic and potentially 
carcinogenic metabolites of fructose are plausibly present in foods 
derived from glyphosate-resistant crops. These include glyoxylate, 
glyoxal and methylglyoxal. Methylglyoxal is implicated in cataract 
development by inducing endoplasmic reticulum stress in human 
lens epithelial cells, and activating an unfolded protein response 
leading to overproduction of ROS and altering the cellular redox 
balance toward lens oxidation [12]. A study on rats conducted by 
Séralini  GE et al., demonstrated that female rats fed with GM maize, 
treated with glyphosate had very high propensity of developing 
mammary fibroadenomas and adenocarcinomas [13]. Glyphosate 
has been in use in India for a long time and our patient was also 
involved in agricultural activities but there is insufficient evidence 
which can explain its use as a cause of EOC and/or breast cancer 
in our patient.
[Table/Fig-2]: (a) Patient having bilateral early-onset nuclear sclerosis-type mature 
cataract at presentation; (b) Patient after small-incision cataract surgery in her left eye 
with good restoration of vision.
[Table/Fig-3]: T1 and T2-weighted images of breast Magnetic Resonance Imaging 
(MRI) showing a large ill-defined altered signal intensity infiltrative mass lesion 
involving almost the entire right breast with diffuse thickening of the skin with chest 
wall invasion.
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CONCLUSION
The evidence linking early-onset cataract with cancer is new and 
needs to be studied in more detail. However, this potential association 
can improve our understanding of cancer pathogenesis.
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